Loss of Dnmt3a and endogenous KrasG12D/+ cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis
Authors:
Open Access
- 24 March 2015
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 29 (9) , 1847-1856
Abstract
Oncogenic NRAS and KRAS mutations are prevalent in human juvenile and chronic myelomonocytic leukemia (JMML/CMML). However, additional genetic mutations cooperating with oncogenic RAS in JMML/ CMML progression and/or their transformation to acute myeloid leukemia (AML) remain largely unknown. Here we tested the potential genetic interaction of DNMT3A mutations and oncogenic RAS mutations in leukemogenesis. We found that Dnmt3a−/− induces multiple hematopoietic phenotypes after a prolonged latency, including T-cell expansion in the peripheral blood, stress erythropoiesis in the spleen and myeloid malignancies in the liver. Dnmt3a−/− significantly promoted JMML/CMML progression and shortened the survival of KrasG12D/+ mice in a cell-autonomous manner. Similarly, downregulating Dnmt3a also promoted myeloid malignancies in NrasG12D/+ mice. Further studies show that Dnmt3a deficiency rescues KrasG12D/+-mediated depletion of hematopoietic stem cells and increases self-renewal of KrasG12D/+ myeloid progenitors (MPs). Moreover, ~33% of animals developed an AML-like disease, which is driven by KrasG12D/+; Dnmt3a−/− MPs. Consistent with our result, COSMIC database mining demonstrates that the combination of oncogenic RAS and DNMT3A mutations exclusively occurred in patients with JMML, CMML or AML. Our results suggest that DNMT3A mutations and oncogenic RAS cooperate to regulate hematopoietic stem and progenitor cells and promote myeloid malignancies.Keywords
This publication has 33 references indexed in Scilit:
- Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformationBlood, 2015
- DNMT3AMutations in Acute Myeloid LeukemiaNew England Journal of Medicine, 2010
- Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1Journal of Clinical Oncology, 2010
- Oncogenic Kras Initiates Leukemia in Hematopoietic Stem CellsPLOS Biology, 2009
- Oncogenic Kras-induced leukemogeneis: hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformationBlood, 2009
- 250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid MalignanciesCancer Research, 2008
- Ablation of de novo DNA methyltransferase Dnmt3a in the nervous system leads to neuromuscular defects and shortened lifespanDevelopmental Dynamics, 2007
- Oncogenic NRAS rapidly and efficiently induces CMML- and AML-like diseases in miceBlood, 2006
- Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorderProceedings of the National Academy of Sciences, 2003
- Inducible Gene Targeting in MiceScience, 1995